StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Yarrow Bioscience's enterprise value was -$10.86M on Nov 11, 2026, against -$32.03M a year earlier. Over the last 5 years it ranged from -$61.87M to $1.68M, with a median of -$22.01M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$10.86M–
2025Dec 31, 2025-$28.18M–
2024Dec 31, 2024-$20.77M–
2023Dec 29, 2023-$7.75M–
2022Dec 30, 2022-$26.81M-1699.1%
2021Dec 31, 2021$1.68M-99.2%
2020Dec 31, 2020$221.32M+1524.1%
2019Dec 31, 2019$13.63M–
2018Dec 31, 2018-$56.95M–

More Yarrow Bioscience figures

See a number that looks wrong?